[Federal Register Volume 81, Number 94 (Monday, May 16, 2016)]
[Notices]
[Pages 30316-30317]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-11428]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App. 2), notice is hereby given of the joint meeting 
of the National Cancer Advisory Board (NCAB) and NCI Board of 
Scientific Advisors (BSA).
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
Web site (http://videocast.nih.gov).
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board; Ad Hoc 
Subcommittee on Global Cancer Research.
    Open: June 20, 2016, 4:30 p.m. to 6:00 p.m.
    Agenda: Discussion on Global Cancer Research.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, Maryland 20814.
    Contact Person: Dr. Edward Trimble, Executive Secretary, NCAB Ad 
Hoc Subcommittee on Global Cancer Research, National Cancer 
Institute--Shady Grove, National Institutes of Health, 9609 Medical

[[Page 30317]]

Center Drive, Room 3W562, Bethesda, MD 20892, (240) 276-5796, 
[email protected].

    Name of Committee: National Cancer Advisory Board and Board of 
Scientific Advisors.
    Open: June 21, 2016, 8:00 a.m. to 4:00 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board, and 
NCI Board of Scientific Advisors; NCI Board of Scientific Advisors 
Concepts Review, NCI Acting Director's report.
    Closed: June 21, 2016, 4:00 p.m. to 5:30 p.m.
    Agenda: Review of NCAB grant applications.
    Place: National Institutes of Health, Building 31, C-Wing, 6th 
Floor, Room 10, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, Room 
7W444, Bethesda, MD 20892, 240-276-6340, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page:
    NCAB: http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm,
    BSA: http://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 10, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-11428 Filed 5-13-16; 8:45 am]
 BILLING CODE 4140-01-P